Having CLL alongside stage 3 kidney disease is a real concern, but it doesn't automatically disqualify someone from chemotherapy. It does mean the treatment plan needs to be carefully thought through.
Here's what's important to know:
- Most CLL treatments are not considered outright dangerous to the kidneys
- Your healthcare Show Full Answer
Having CLL alongside stage 3 kidney disease is a real concern, but it doesn't automatically disqualify someone from chemotherapy. It does mean the treatment plan needs to be carefully thought through.
Here's what's important to know:
- Most CLL treatments are not considered outright dangerous to the kidneys
- Your healthcare team will weigh the benefits and risks of each treatment option based on your kidney function
- Regular kidney monitoring during treatment is standard practice in this situation
- Some chemotherapy drugs may affect kidney function more than others, so your team may favor certain options over others It's also worth knowing that for CLL specifically, chemotherapy is actually used far less often these days. Targeted therapy drugs like ibrutinib (Imbruvica) or venetoclax (Venclexta) are now the preferred first-line treatments and may be gentler options to explore.
The most important step is making sure your oncologist and kidney specialist are communicating closely with each other. As one MyLeukemiaTeam member shared, having a nurse or specialist actively monitoring kidney markers like creatinine levels during treatment made a significant difference in catching problems early.
Always bring up your kidney disease directly with your oncologist before any treatment begins — this conversation is essential.
July 15
Join
Your Privacy Choices
